Actively Recruiting

Phase Not Applicable
All Genders
NCT05629130

Embolization in Hereditary Coagulopathies

Led by University of Sao Paulo General Hospital · Updated on 2022-11-29

30

Participants Needed

1

Research Sites

363 weeks

Total Duration

On this page

Sponsors

U

University of Sao Paulo General Hospital

Lead Sponsor

M

Merit Medical Systems, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a longitudinal, prospective study, which will include 30 subjects with hereditary coagulopathies, with arthropathy, chronic synovitis resulting from hemarthrosis of the elbows, knees and/or ankles followed up at the Centro de Hemofilia HCFMUSP, after approval by the ethics and research committee. They will undergo imaging tests (X-rays and Magnetic Resonance of knee, elbow, or ankle), physical, pain, quality of life and functional assessments (Hemophilia Joint Health Score, Functional Independence Score in Hemophilia, Perimeter, Test Timed up and Go, 30 second sit and stand test, Haemophilia - Adult - Quality of Life questionnaire (HAEM-A-QoL), Knee Injury and Osteoarthritis Outcome Score, EQ-5D, numerical rating scale for pain and embolization procedure (superselective embolization of target arteries with spherical microparticles Embosphere 100-300 micrometers (Biosphere Medical, Roissy, France), until partial vascular stasis and decharacterization of pathological synovial enhancement. These evaluations will be performed at baseline, 1, 3, 6, 12, 24, 36, 48 and 60 months after the procedure.

CONDITIONS

Official Title

Embolization in Hereditary Coagulopathies

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with hereditary coagulopathies and arthropathy caused by chronic synovitis from hemarthrosis
  • X-ray and MRI documenting synovitis of the affected joints
  • Patients followed up at the Hemophilia Center HC-FMUSP
Not Eligible

You will not qualify if you...

  • Patients who do not complete the planned assessments
  • Patients who do not accept to continue with the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Instituto de Ortopedia e Traumatologia do Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo

São Paulo, Brazil, 05403-010

Actively Recruiting

Loading map...

Research Team

M

marcia u rezende, MD PhD

CONTACT

F

Fabiane E Farias, PT

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Embolization in Hereditary Coagulopathies | DecenTrialz